DCRI @ ACC

DCRI at ACC.24
Atlanta | April 6–8, 2024 | Booth 1923

DCRI experts are excited to share and discuss the latest scientific developments in cardiology with our partners from around the globe at the American College of Cardiology 73rd Annual Scientific Session & Expo April 6–8 in Atlanta. Our faculty, fellows, and operational experts will showcase thought leadership and inspire peer providers to turn knowledge into clinical practice through late-breaking clinical trial sessions, presentations, panel discussions, and collaborator meetings. Click the links below to learn more about DCRI's presence at ACC.24.

Quick Links: DCRI Presentations  |  News from ACC  |  DCRI Expertise

Presentations

DCRI faculty and thought leaders will contribute to over 75 sessions this year including presentations, panel discussions, debates, mentorship events, and moderated poster sessions. We will cover topics ranging from interventional therapies, drug comparisons, professional equity, guideline adherence, and more.

Meet the Experts

AEGIS-II

Saturday, April 6 from noon-1 p.m. at DCRI Booth, no. 1923

Drs. Thomas Povsic and John Alexander

Join co-investigators Thomas Povsic, MD, PhD, and John H. Alexander, MD, MHS, following the AEGIS-II late-breaking session to learn more about the study, its successful enrollment of 18,226 patients in 46 countries, and how the DCRI managed 193 U.S. sites with more than 1,800 high-risk acute MI patients, mainly during the COVID-19 pandemic.

V-INCLUSION

Monday, April 8 from 11 a.m.-noon at DCRI Booth, no. 1923

Dr. Neha Pagidipati

Speak with Neha Pagidipati, MD, MPH, about her upcoming study. V-INCLUSION will recruit approximately 1,440 racially, ethnically, and geographically diverse participants who have historically been underrepresented in clinical research. The trial will measure the effectiveness of usual care + inclisiran in those with established ASCVD or those at high risk.

DCRI Late-Breaker and Featured Presentations

Saturday, April 6, 2024

9:50–10:02 a.m.  |  Hall B-1 Main Tent

402-10 — Empagliflozin After Acute Myocardial Infarction: Results Of The EMPACT-MI Trial with contributions from DCRI Faculty Schuyler Jones, MD, and Adrian Hernandez, MD, MHS

10:10–10:22 a.m.  |  Hall B-1 Main Tent

402-10 — CSL112 (Apolipoprotein A-I) Infusions And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results with contributions from DCRI Faculty John Alexander, MD, MHS, Renato D. Lopes, MD, PhD, FACC, and Thomas J. Povsic, MD, PhD

 

Sunday, April 7, 2024

10:00–10:10 a.m.  |  Hall B-1 Main Tent

406-10 — Effect Of Edetate Disodium Based Chelation Infusions On Cardiovascular Events In Post-MI Patients With Diabetes: The TACT2 Trial with contributions from DCRI Experts Daniel Mark, MD, and Kevin Anstrom, PhD, MHS

12:15–1:30 p.m.  |  Hall B-1 Main Tent

407 — Featured Clinical Research II with DCRI Faculty Panelists Neha J. Pagidipati, MD, MPH, and Robert J. Mentz, MD

2:00–3:15 p.m.  |  Hall B-1 Main Tent

408 — Late-Breaking Clinical Trials Deep Dive I with DCRI Faculty Discussant Robert J. Mentz, MD

 

Monday, April 8, 2024

2:30–3:45 p.m.  |  Hall B-1 Main Tent

414 — Late-Breaking Clinical Trials Deep Dive II with DCRI Faculty Discussant Manesh Patel, MD

DCRI News from ACC.24

Check back on April 6, 2024, to read late-breaking news from DCRI at ACC.24!

 

ACC.24 Social Media

Stay connected with the following hashtag: #ACC24

Follow DCRI's Insights Live at ACC.24
Twitter X Logo
LinkedIn

Learn More About DCRI Expertise

two doctors talking

Transforming the Future of CV Care

Learn why the world looks to the DCRI as the definitive leader in cardiovascular clinical research, implementation science, and education.

U.S. map

Beyond CV

DCRI expertise extends beyond cardiovascular research. Visit our DCRI At-A-Glance page to learn quick facts about the world's largest academic research organization.

two people shaking hands

DCRI Studies Recruiting Sites & Participants

The DCRI, together with its esteemed site community partners, is addressing clinical research challenges that will shape the future of medical care for years to come. Would you like to partner with the DCRI? View DCRI studies across therapeutic areas currently recruiting sites and/or participants.